Literature DB >> 1317257

Expression of the epidermal growth factor receptor in human small cell lung cancer cell lines.

L Damstrup1, K Rygaard, M Spang-Thomsen, H S Poulsen.   

Abstract

Epidermal growth factor (EGF) receptor expression was evaluated in a panel of 21 small cell lung cancer cell lines with radioreceptor assay, affinity labeling, and Northern blotting. We found high-affinity receptors to be expressed in 10 cell lines. Scatchard analysis of the binding data demonstrated that the cells bound between 3 and 52 fmol/mg protein with a KD ranging from 0.5 x 10(-10) to 2.7 x 10(-10) M. EGF binding to the receptor was confirmed by affinity-labeling EGF to the EGF receptor. The cross-linked complex had a M(r) of 170,000-180,000. Northern blotting showed the expression of EGF receptor mRNA in all 10 cell lines that were found to be EGF receptor-positive and in one cell line that was found to be EGF receptor-negative in the radioreceptor assay and affinity labeling. Our results provide, for the first time, evidence that a large proportion of a broad panel of small cell lung cancer cell lines express the EGF receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317257

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

Review 1.  Molecular genetic abnormalities in the pathogenesis of human lung cancer.

Authors:  E Forgacs; S Zöchbauer-Müller; E Oláh; J D Minna
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

2.  Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.

Authors:  G Halmos; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

3.  Primary neuroendocrine small cell undifferentiated carcinoma of the parotid gland.

Authors:  S Jorcano; A Casado; J Berenguer; M Arenas; A Rovirosa; L Colomo
Journal:  Clin Transl Oncol       Date:  2008-05       Impact factor: 3.405

Review 4.  EGF receptor in neoplasia and metastasis.

Authors:  K Khazaie; V Schirrmacher; R B Lichtner
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

5.  Mass spectrometric characterization of a series of adenosylated peptides acting as bisubstrate analogs of protein kinases.

Authors:  B W Gibson; D Medzihradszky; W M Hines; S Auriola; G L Kenyon
Journal:  J Am Soc Mass Spectrom       Date:  1994-05       Impact factor: 3.109

6.  Gene silencing for epidermal growth factor receptor variant III induces cell-specific cytotoxicity.

Authors:  Farnaz Yamoutpour; Vidya Bodempudi; Shay E Park; Weihong Pan; Mary Jean Mauzy; Robert A Kratzke; Arkadiusz Dudek; David A Potter; Richard A Woo; Donald M O'Rourke; Donald J Tindall; Faris Farassati
Journal:  Mol Cancer Ther       Date:  2008-11       Impact factor: 6.261

7.  Prediction of inhibitory activity of epidermal growth factor receptor inhibitors using grid search-projection pursuit regression method.

Authors:  Hongying Du; Zhide Hu; Andrea Bazzoli; Yang Zhang
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

8.  Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue.

Authors:  K J O'Byrne; J T Ennis; P J Freyne; L J Clancy; J S Prichard; D N Carney
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

9.  Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines.

Authors:  L Damstrup; K Rygaard; M Spang-Thomsen; H Skovgaard Poulsen
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

10.  Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.

Authors:  J Pinski; A V Schally; G Halmos; K Szepeshazi; K Groot; K O'Byrne; R Z Cai
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.